在癌症预防中,多和肠道微生物群之间的分子交叉
Falak Zeb1, Huma Naqeeb2, Tareq Osaili3
1Research Institute for Medical and Health Sciences, University of Sharjah, United Arab Emirates.
Nutrition research (New York, N.Y.)
|February 16, 2024
概括
多和肠道微生物群在预防癌症方面表现有前途. 它们的分子交叉影响癌症路径,为个性化癌症治疗提供了针对多-肠轴的新疗法策略.
科学领域:
- 微生物学 微生物学
- 营养科学 营养科学
- 在瘤学瘤学.
背景情况:
- 癌症是全球主要的健康问题,需要新的治疗方法.
- 来自植物的多具有抗氧化,抗炎和抗癌的特性.
- 肠道微生物群显著影响宿主健康和疾病风险.
研究的目的:
- 审查肠道微生物群在癌症抑制和瘤发生中的机制.
- 探索肠道微生物群调节和多生物转化之间的相互作用.
- 讨论这种相互作用对预防癌症的治疗潜力.
主要方法:
- 关于动物和人类研究的文献综述.
- 对协同效应的分子机制的分析.
- 检查信号通路,免疫反应和表观遗传修饰.
主要成果:
- 肠道微生物群和多相互作用复杂,影响癌症的发展.
- 协同效应涉及对宿主分子通路和免疫反应的调节.
- 肠道微生物群的个体间差异需要个性化的方法.
结论:
- 多-肠轴为癌症预防和治疗提供了一个有前途的途径.
- 了解这种交叉通话可以导致个性化癌症治疗.
- 进一步的临床试验对于验证这些发现至关重要.
更多相关视频
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


